Rx Droncit 56.8 mg x 10 ml injectable

Droncit Injectable Droncit Injectable Cestocide are indicated for the removal of tapeworm infections in dogs and cats. Droncit is the most tried and trusted dewormer to eliminate tapeworms. Droncit contains praziquantel for effective, reliable relief of tapeworms transmitted by fleas. Prescription items are NON-RETURNABLE and NON-REFUNDABLE. - CAUTIONS/WARNINGS:Overdosage The safety index has been derived from controlled safety evaluations, clinical trials and prior approved use in foreign countries. Dosages of 5 times the labeled rate at 14 day intervals to dogs as young as 4 weeks did not produce signs of clinical toxicity following either intramuscular or subcutaneous injections. No significant clinical chemistry, hematological, cholinesterase or histopathological changes occurred. Dosages of 5 times the labeled rate at 14 day intervals to kittens as young as 5 1/2 weeks did not produce signs of clinical toxicity following either intramuscular or subcutaneous injections. Symptoms of overdosage (33.8 to 40 times the labeled dosage rate) in adult dogs included vomition, excessive salivation and depression, but no deaths. Symptoms of overdosage (10 to 20 times the labeled dosage rate) in adult cats included vomition, depression, muscle tremors and incoordination. Deaths occurred in 5 of 8 cats treated subcutaneously and in all 8 injected intramuscularly at doses greater than 20 times the label rate. CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. CONTRAINDICATIONS: There are no known contraindications to the use of praziquantel. PREGNANCY: Droncit (praziquantel) has been tested in breeding and pregnant dogs and cats. No adverse effects were noted. ADVERSE REACTIONS: Mild side effects were observed in 18 of 189 dogs (9.5%) and 8 of 85 cats (9.4%) administered Droncit Injectable in field trials. For dogs the majority of these were described as brief pain responses following injections to larger dogs (weighing over 50 lbs.). Two dogs exhibited a brief period of mild vomiting and/or drowsy or staggering gait. The eight cats exhibited either diarrhea, weakness, vomition, salivation, sleepiness, burning on injection and/or a temporary lack of appetite. Local irritation or swelling at the site of subcutaneous injections have been reported for cats. WARNING: Keep out of the reach of children. Not for human use. For customer service or to obtain product information, including Material Safety Data Sheet, call 1-800-633-3796. - DIRECTIONS:DIRECTIONS: Droncit (praziquantel) Injectable Cestocide may be administered by either the subcutaneous or intramuscular route to dogs and cats. The recommended dosage of praziquantel varies according to body weight. Smaller animals require a relatively larger dosage. The optimum dosage for each individual animal will be achieved by utilizing the following dosage schedule. Dogs and Puppies* Dosage Amount 5 lbs. and Under 0.3 ml 6-10 lbs 0.5 ml 11-25 lbs 1 ml Over 25 lbs 0.2 ml/5 lbs Body Weight to a maximum of 3 ml *Not intended for use in puppies less than 4 weeks of age. Cats and Kittens* Dosage Amount 5 lbs. and Under 0.2 ml 5-10 lbs 0.4 ml 11 and Over 0.6 ml maximum *Not intended for use in kittens less than 6 weeks of age. FASTING: The recommended dosage of praziquantel is not affected by the presence or absence of food in the gastrointestinal tract, therefore, FASTING IS NEITHER NECESSARY NOR RECOMMENDED. Administration Droncit (praziquantel) Injectable Cestocide may be administered by either the subcutaneous or intramuscular route to dogs and cats. The intramuscular route may be preferred in dogs due to a brief period of pain that occasionally follows subcutaneous administration. Anaphylactoid reactions were not observed in clinical trials. However, as with any drug an anaphylactoid reaction can occur with this product and should be treated symptomatically if it occurs. RETREATMENT: For those animals living where reinfections are likely to occur, clients should be instructed in the steps to optimize prevention, otherwise, retreatment may be necessary. This is true in cases of Dipylidium caninum where reinfection is almost certain to occur if fleas are not removed from the animal and its environment. In addition, for control of Echinococcus multilocularis, a program of regular treatment every 21 to 26 days may be indicated. - INGREDIENTS:Ingredients: Droncit Injectable Cestocide is a clear solution containing 56.8 milligrams of praziquantel per mL which has been formulated for subcutaneous or intramuscular use in dogs and cats for removal of cestodes (tapeworms). - HEIGHT(INCHES): 1.000 - WIDTH(INCHES):1.000 - LENGTH(INCHES):1.000